KLF4 re-expression also sensitized NALM-6 cells to chemotherapy in vitro (Supplementary Figure S10) confirming the results obtained from PDX B-ALL cells in vivo. This evidence concerns the gene KLF4 and acute lymphoblastic leukemia.